RESUMO
Six healthy beagle dogs were infected with Leishmania infantum (MCAN/ES/92/BCN-83/MON-1) by intravenous inoculation of 5 x 10(7) promastigotes and two others were used as controls. When animals showed clinical signs of disease at 29, 37, 41 and 45 weeks post-infection (p.i.), they were treated with meglumine antimoniate (20.4 mg Sb/kg/12 h) subcutaneously for two periods of 10 days each. Sera were tested periodically for Leishmania antibodies by Dot-ELISA, ELISA and Western blot (WB). Aspirates of popliteal lymph node (PLN), peripheral blood sample (PB) and healthy skin were cultured in NNN and Schneider's medium. PLNs were positive between 8 and 20 weeks p.i. and in one animal PB was positive 6 weeks p.i. Samples of healthy skin, obtained before treatment, were also positive. Dot-ELISA and ELISA detected specific antibodies at an early stage between 4 and 12 weeks p.i and surpassed the cut-off between 16-24 weeks p.i., while the WB was positive between 10-19 weeks p.i. The pattern of bands revealed during the first stages of infection was variable and only in two cases did the positivity start with bands of low molecular weight (12-14 kD); the number of bands increased until 15-24 weeks p.i., after which sera revealed a complete pattern of bands, from 12 to 85 kD, in the antigen of Leishmania. After treatment the clinical improvement of the animals was accompanied by a decrease in antibody titers (Dot-ELISA and ELISA) although the parasites remained in the PLN. This was reflected in the WB by a decrease in the intensity of bands, especially those in the region of 12-30 kD. A new increase in the antibody levels between 3 and 5 months after terminating the therapy was detected in the WB by a restoration of the initial complete pattern of bands.
Assuntos
Antiprotozoários/uso terapêutico , Doenças do Cão/tratamento farmacológico , Leishmania infantum/efeitos dos fármacos , Leishmaniose Visceral/veterinária , Meglumina/uso terapêutico , Compostos Organometálicos/uso terapêutico , Animais , Anticorpos Antiprotozoários/análise , Biópsia/veterinária , Sangue/parasitologia , Western Blotting/veterinária , Doenças do Cão/parasitologia , Cães , Eletroforese em Gel de Poliacrilamida/veterinária , Ensaio de Imunoadsorção Enzimática/veterinária , Leishmaniose Visceral/tratamento farmacológico , Linfonodos/parasitologia , Antimoniato de Meglumina , Pele/parasitologiaRESUMO
An epidemiological survey of canine leishmaniosis was conducted in the Priorat, a rural region in the Northeast of Spain, for 10 years (1985-1994). Seroprevalence throughout the region, determined by dot-ELISA and IFI, was 10.2% (8-12%). Forty percent of the dogs studied had a low level of anti-Leishmania antibodies, whereas only 50% were seronegative. Only one-third of the seropositive dogs had evident symptoms of the disease. Annual incidence of the disease was 5.7% and the level of endemicity was stable during the study. Four Leishmania zymodemes (MON-1, MON-29, MON-77, MON-105) were present in the focus, and their distribution in the different hosts is discussed. Apart from dogs and foxes, no other reservoir host has been found in the region.
Assuntos
Doenças do Cão/epidemiologia , Leishmania infantum/imunologia , Leishmaniose Visceral/veterinária , Fatores Etários , Animais , Anticorpos Antiprotozoários/sangue , Reservatórios de Doenças , Cães , Eletroforese/veterinária , Ensaio de Imunoadsorção Enzimática/veterinária , Feminino , Técnica Indireta de Fluorescência para Anticorpo/veterinária , Raposas , Cabras , Incidência , Isoenzimas , Leishmaniose Visceral/epidemiologia , Masculino , Roedores , População Rural , Estudos Soroepidemiológicos , Fatores Sexuais , Ovinos , Espanha/epidemiologiaRESUMO
Serum samples collected from 237 dogs in Catalonia (northeastern Spain) were screened by Western blot analysis to detect the presence of antibodies specific to different Leishmania infantum polypeptide fractions. Leishmaniasis was confirmed in 72 of these dogs by direct examination and/or culture. Another 165 animals from the Priorat region were studied periodically for 2-8 years between 1987 and 1995, giving a total of 565 determinations. A control group of 93 dogs from nonendemic areas was also studied. Sera from dogs with leishmaniasis recognized antigens with molecular weights ranging from 12 to 85 kD. The most sensitive antigens were those of 70, 65, 46, 30, 28, 14, and 12 kD, which were recognized by 75%, 75%, 78%, 75%, 81%, 79%, and 75%, respectively, of the sera from dogs with positive parasitologic examination results. Antigens of 70 and 65 kD were also recognized by two dogs from nonendemic areas. Antigens of 14 and 12 kD were the first to be recognized by sera of asymptomatic dogs with titers less than the cut-off value of the dot-ELISA that increased during the longitudinal study, and the presence of antibodies specific for these fractions was observed for up to six years before seroconversion observed by dot-ELISA. These antibodies were also the first to disappear in dogs in which the disease was self-limited. The study corroborates the high sensitivity and specificity of Western blots in the diagnosis of canine leishmaniasis when the bands of low molecular weight (less than 46 kD) are considered, and indicates that fractions of 14 and 12 kD are useful in detecting early forms of the disease.
Assuntos
Anticorpos Antiprotozoários/sangue , Western Blotting/veterinária , Doenças do Cão/diagnóstico , Leishmania infantum/imunologia , Leishmaniose Visceral/veterinária , Animais , Antígenos de Protozoários/química , Antígenos de Protozoários/imunologia , Estudos de Coortes , Doenças do Cão/epidemiologia , Cães , Ensaio de Imunoadsorção Enzimática/veterinária , Leishmaniose Visceral/diagnóstico , Leishmaniose Visceral/epidemiologia , Peso Molecular , Sensibilidade e Especificidade , Espanha/epidemiologiaRESUMO
A dot-enzyme-linked immunosorbent assay (ELISA) using protein A-peroxidase was evaluated as a diagnostic test for canine leishmaniasis. The test results were in agreement with parasitologic diagnosis and indirect immunofluorescence assay results. The sensitivity of the test calculated on 31 dogs with positive parasitologic examination was 90% when a titer of 1/800 was established as a cutoff and 100% when a titer of 1/400 was established. The specificity calculated on the canine population from nonendemic areas was 100% when both titers were established. Nevertheless, in endemic areas titers near the cutoff need careful interpretation. The results of this study demonstrate that dot-ELISA protein A using a bio-dot apparatus is highly suitable for seroepidemiologic field work.
Assuntos
Doenças do Cão , Leishmaniose/veterinária , Animais , Anticorpos Antiprotozoários/sangue , Cães , Doenças Endêmicas/veterinária , Ensaio de Imunoadsorção Enzimática/métodos , Técnica Indireta de Fluorescência para Anticorpo , Leishmania/isolamento & purificação , Leishmaniose/diagnóstico , Leishmaniose/epidemiologia , Linfonodos/parasitologia , Linfonodos/patologia , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Testes Sorológicos , Espanha/epidemiologiaRESUMO
The changes in the titres of anti-leishmania antibodies in 25 dogs with leishmaniasis were studied by using a Dot-ELISA technique while they were being treated with N-methylglucamine and allopurinol. When the diagnosis of leishmaniasis was established, 21 of the dogs had positive titres (1:800 or higher), and after treatment, 15 of them still had high titres, in most cases the same as at the point of the diagnosis. In four dogs the titres decreased, and were less than the cut-off value in two cases nine months after treatment. Only four dogs had titres less than the cut-off value when they were diagnosed, but one month later the titres in all four dogs had reached the cut-off value. There was no correlation between the serological titres and the severity of the clinical signs. It is concluded that the Dot-ELISA is a sensitive method for the diagnosis of canine leishmaniasis but is not satisfactory for monitoring the clinical development of the disease.
Assuntos
Anticorpos Antiprotozoários/sangue , Doenças do Cão/diagnóstico , Doenças do Cão/tratamento farmacológico , Leishmania infantum/imunologia , Leishmaniose Visceral/veterinária , Alopurinol/uso terapêutico , Animais , Cães , Monitoramento de Medicamentos , Quimioterapia Combinada , Ensaio de Imunoadsorção Enzimática/veterinária , Feminino , Leishmaniose Visceral/diagnóstico , Leishmaniose Visceral/tratamento farmacológico , Masculino , Meglumina/uso terapêutico , Sensibilidade e EspecificidadeRESUMO
Two polypeptide fractions of 72-75 kD were detected in the urine of 14 of 15 patients with visceral leishmaniasis (VL) and another fraction of 123 kD was found in 10 of the 15 patients by using a Western blot technique. None of these fractions was detected in the urine of 20 controls. These results suggest that antigen detection in urine could be a powerful, noninvasive method for VL diagnosis.